Tumor necrosis factor inhibitors contribute to a greater susceptibility to infection\nor reactivation of Mycobacterium tuberculosis . Endobronchial tuberculosis\nhas non-specific symptoms, which may delay the diagnosis. We report\na case of a 21-year-old woman, with Crohnâ??s disease, medicated with adalimumab.\nThe patient presented with a 2-week history of fever, dry cough,\npleuritic chest pain and weight loss of 2 kg. Chest imaging showed bilateral\nnodular opacities, at the right pulmonary apex. Bronchoscopy revealed a tumorous\nlesion in the right upper bronchus. Bronchial biopsies were suggestive\nof chronic granulomatous inflammation. Bronchoalveolar lavage produced\na positive for acid-fast bacilli smear and culture for Mycobacterium\ntuberculosis. We assumed the diagnosis of tuberculosis with endobronchial\nmanifestations. Nowadays this is a rare manifestation. Empirical treatment\nfor tuberculosis was initiated, with steroids as an adjunct therapy to prevent\nbronchostenosis, with clinical and radiological improvement.
Loading....